Table 5.

Acute effects of benzo[a]pyrene on GSH level (mean ± SD, n = 10).

Group	Time	Liver	Lung	Kidney	Stomach	Brain
Control	24	40.23 ± 5.64	49.32 ± 7.38	48.83 ± 6.71	47.93 ± 4.11	19.02 ± 4.73
12.5 mg/kg	24	58.96 ± 5.81c	62.12 ± 4.09c	68.07 ± 6.88c	68.84 ± 5.44c	35.71 ± 5.21c
25 mg/kg	24	56.42 ± 5.39c	60.73 ± 5.45c	64.26 ± 8.79c	66.44 ± 4.99c	32.60 ± 6.01c
50 mg/kg	24	52.94 ± 4.60c	57.78 ± 4.16b	60.25 ± 4.77c	63.39 ± 3.77c	27.76 ± 5.11c
100 mg/kg	24	50.47 ± 5.12c	53.52 ± 5.21	57.25 ± 6.23a	61.42 ± 3.13c	25.63 ± 4.11b
Control	48	39.62 ± 5.45	48.55 ± 7.42	47.25 ± 6.52	46.63 ± 4.52	18.23 ± 4.68
12.5 mg/kg	48	56.29 ± 6.95c	57.70 ± 5.80b	63.26 ± 7.09c	63.99 ± 4.56c	32.43 ± 5.57c
25 mg/kg	48	53.43 ± 5.85c	56.89 ± 5.58a	62.80 ± 6.41c	62.94 ± 4.95c	30.23 ± 6.62c
50 mg/kg	48	50.37 ± 5.57c	53.18 ± 4.16	58.21 ± 4.33c	60.28 ± 3.32c	25.08 ± 4.64b
100 mg/kg	48	47.75 ± 5.24b	51.42 ± 4.85	53.21 ± 5.11a	58.24 ± 4.45c	23.86 ± 4.42a
Control	72	39.12 ± 5.66	47.67 ± 7.51	46.68 ± 6.34	45.14 ± 4.33	18.14 ± 4.58
12.5 mg/kg	72	52.45 ± 6.96c	52.47 ± 4.35	60.73 ± 9.94b	58.69 ± 5.05c	30.83 ± 5.78c
25 mg/kg	72	51.14 ± 6.06c	52.12 ± 6.57	57.31 ± 8.48b	58.53 ± 3.03c	26.54 ± 5.72b
50 mg/kg	72	47.25 ± 6.02b	51.36 ± 4.62	54.03 ± 6.67a	57.22 ± 3.72c	22.13 ± 4.14
100 mg/kg	72	45.56 ± 5.31a	50.63 ± 5.14	50.03 ± 5.74	57.14 ± 4.31c	21.81 ± 4.06

^aP < 0.05.

^bP < 0.01.

^cP < 0.001 between the corresponding control and B[a]P treatment groups, respectively.